• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Gilead Sciences(GILD.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Jan1
Zacks Research Raises Gilead Sciences' Earnings Forecast to $2.34 Per Share
11:03
Dec30
Gilead Sciences Reaches Agreement with US Government to Lower Drug Costs
23:02
Gilead Sciences CEO Daniel O'Day Selling Company Common Stock
21:23
Dec24
Gilead Sciences to Acquire Repare Therapeutics' Cancer Treatment Drugs
12:38
Global X Japan Co. Ltd. Significantly Increases Holdings in Gilead Sciences
09:44
Dec23
Gilead's Seladelpar Approved in Bo'ao, Hainan
02:45

Schedules & Filings

Schedules
Filings
Dec30
Distribution Plan(EST)

Cash dividend 0.79 USD

Dec15
Distribution Plan(EST)

Cash dividend 0.79 USD

Distribution Plan(EST)

Cash dividend 0.79 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More